 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
Details |
|
A Phase II Trial of Bevacizumab (avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
|
|
Details |
|
A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
Details |
|
Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma |
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
|
Toronto, Ontario, CANADA
Bethesda, MD
New York, NY
Cincinnati,, OH
Columbus, OH |
|
04/21/2009 |
|
|
|
Details |
|
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma |
|
Bethesda, MD |
|
04/15/2009 |
|
|
|
|
|
Details |
|
Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
|
Houston, TX |
|
04/14/2009 |
|
|
|
Details |
|
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
|
San Francisco, CA |
|
04/06/2009 |
|
|
|
|
|
Details |
|
Phase I Pilot Study of HLA-A2-Restricted Synthetic Glioma Antigen Peptide Vaccine and Poly ICLC Vaccine in Young Patients With Newly Diagnosed Malignant or Intrinsic Brain Stem Glioma, Incompletely Resected Non-Brainstem High-Grade Glioma, or Recurrent Unresectable Low-Grade Glioma |
|
Pittsburgh, PA |
|
03/16/2009 |
|
|
|
Details |
|
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
|
Santa Monica, CA |
|
11/29/2008 |
|
|
|
|
|
Details |
|
Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
|
|
San Francisco, CA
Washington, DC
Chicago, IL
Boston, MA
Bethesda, MD
Durham, NC
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Seattle, WA |
|
11/08/2008 |
|
|
|
Details |
|
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
|
Houston, TX |
|
10/27/2008 |
|
|
|
|
|
Details |
|
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/27/2008 |
|
|
|
Details |
|
BIBW 2992 with or without daily temozolomide in the treatment of
patients with recurrent malignant glioma
|
|
Charlottesville, VA |
|
10/20/2008 |
|
|
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
|
Boston, MA
New York, NY
Houston, TX
Charlottesville, VA |
|
10/09/2008 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Charlottesville, VA |
|
09/30/2008 |
|
|
|
|
|
Details |
|
Gliogene: An International Brain Tumor Study |
|
Houston, TX |
|
07/24/2008 |
|
|
|
Details |
|
Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
05/28/2008 |
|
|
|
|
|
Details |
|
Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma |
|
Houston, TX |
|
05/28/2008 |
|
|
|
Details |
|
Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme |
|
Houston , TX |
|
04/27/2008 |
|
|
|
|
|
Details |
|
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Los Angeles, CA
Boston, MA
Durham, NC
New York, NY
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma |
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma) |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas |
|
Pittsburgh, PA |
|
03/02/2008 |
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Kingston, Ontario, CANADA
Edmonton, Alberta, CANADA
Moncton, New Brunswick, CANADA
Ottawa, Ontario, CANADA
Toronto, Ontario, CANADA
Winnipeg, Manitoba, CANADA
Phoenix, AZ
La Jolla, CA
Palo Alto, CA
Sacramento, CA
Aurora, CO
Englewood, CO
Jacksonville, FL
Orlando, FL
Chicago, IL
Evanston, IL
Boston, MA
Detroit, MI
Winston-Salem, NC
Edison, NJ
Buffalo, NY
Columbus, OH
Columbus, OH
Portland, OR
Memphis, TN
Nashville, TN
Seattle, WA
Madison, WI |
|
03/01/2008 |
|
|
|
|
|
Details |
|
Gliogene: Brain Tumor Linkage Study |
|
San Francisco, CA
Tampa, FL
Boston, MA
New York, NY
Houston, Tx |
|
01/17/2008 |
|
|
|
Details |
|
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
|
San Francisco, CA |
|
01/17/2008 |
|
|
|
|
|
Details |
|
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
Details |
|
Phase I/II trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine For Patients With Recurrent High Grade Glioma |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Los Angeles, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/03/2007 |
|
|
|
Details |
|
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
|
Duarte, CA
Baltimore, MD |
|
08/31/2007 |
|
|
|
|
|
Details |
|
A Phase IIa Safety and Light Dose-Escalation Study in Patients With Primary or Recurrent/High-Grade Glioma (Defined for the Purposes of the Protocol as Anaplastic Astrocytoma [AA] or Glioblastoma Multiforme [GBM]) Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma |
|
, Serbia |
|
08/26/2007 |
|
|
|
Details |
|
Phase I Study of Enzastaurin and Temozolomide in Patients With Gliomas |
|
Glasgow, Scotland, UK |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status |
|
Boston, MA |
|
08/26/2007 |
|
|
|
Details |
|
The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-Grade Astrocytomas |
|
Bergen, Norway |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors |
|
NEW YORK CITY, NY |
|
08/20/2007 |
|
|
|
Details |
|
A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma |
|
Durham, NC |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas |
|
Vista, CA |
|
08/20/2007 |
|
|
|
Details |
|
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas |
|
Chicago, IL |
|
08/20/2007 |
|
|
|
|
|
Details |
|
Determination of the In-Tumor-Concentration of Imatinib Mesylate (Gleevec) in Malignant Glioma After Oral Administration |
|
Baltimore, MD |
|
08/20/2007 |
|
|
|
Details |
|
Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms |
|
New York, NY |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy |
|
Copenhagen, Denmark |
|
08/18/2007 |
|
|
|
Details |
|
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors |
|
Winston-Salem, NC |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme |
|
Houston, TX |
|
08/18/2007 |
|
|
|
Details |
|
Identification of Hypermethylated Serum Tumor DNA in High Grade Glioma Patients and Correlation with Magnetic Resonance Imaging Findings |
|
Cleveland, OH |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. |
|
Los Angeles, CA
Durham, NC |
|
08/18/2007 |
|
|
|
Details |
|
Phase II Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients with Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Philadelphi, PA |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma |
|
New York, NY |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Brain Mapping for Brain Tumors |
|
Boston, MA |
|
08/18/2007 |
|
|
|
Details |
|
Functional image guided removal of brain tumors |
|
Manhasset, NY |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Gliadel and Dendritic Cell Vaccine for Malignant Glioma |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
Improving Quality Of Life For Brain Tumor Patients |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase 1 Trial Gamma Knife For Primary Brain Tumors - Gliomas. |
|
Birmingham, AL |
|
08/18/2007 |
|
|
|
Details |
|
Phase I Study Of Pioglitazone And Isotretinoin In Patients With Recurrent Or Progressive Malignant Gliomas |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Pilot Study of Bevacizamab in Patients with Recurrent or Progressive Primary Brain Tumors |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma |
|
Los Angeles, CA |
|
08/04/2007 |
|
|
|
|
|
Details |
|
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
|
Los Angeles, CA
Boston, MA
New York, NY
Pittsburgh, PA
Houston, TX
Madison, WI |
|
08/04/2007 |
|
|
|
Details |
|
A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection |
|
Cincinnati , OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
|
Tampa, FL
Atlanta, GA
Chicago, IL
Boston, MA
Detroit, MI
Durham, NC
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
|
Birmingham, AL
Tampa, FL
Atlanta, GA
Boston, MA
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Cleveland, OH
Philadelphia, PA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
|
Detroit, MI |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Phoenix, AZ
New Haven, CT
Lewes, DE
Fort Lauderdale, FL
Jacksonville, FL
Jacksonville, FL
Miami, FL
Columbus, GA
Dubuque, IA
Detroit, MI
Kalamazoo, MI
Lambertville, MI
Rochester, MN
Rochester, MN
Saint Louis Park, MN
Springfield, MO
Omaha, NB
Goldsboro, NC
Lebanon, NH
Long Branch, NJ
Mount Holly, NJ
Albuquerque, NM
Buffalo, NY
Utica, NY
, OH
Akron, OH
Cleveland, OH
Tulsa, OK
Portland, OR
Philadelphia, PA
Philadelphia, PA
Wynnewood, PA
Greenville, SC
Kingsport, TN
Salt Lake City, UT
Madison, WI |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma |
|
Cleveland, OH
Columbus, OH
Portland, OR |
|
05/01/2007 |
|
|
|
Details |
|
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
|
Jacksonville, FL
Boston, MA
Rochester, MN
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Birmingham, AL
Phoenix, AZ
Phoenix, AZ
Downey, CA
Long Beach, CA
Los Angeles, CA
Sacramento, CA
Denver, CO
Jacksonville, FL
St. Petersburg, FL
West Palm Beach, FL
Atlanta, GA
Augusta, GA
Honolulu, HI
Iowa City, IA
Chicago, IL
Park Ridge, IL
New Orleans, LA
Boston, MA
Baltimore, MD
Scarborough, ME
Grand Rapids, MI
Kansas City, MO
Saint Louis, MO
Saint Louis, MO
Omaha, NE
Hackensack, NJ
Summit, NJ
Las Vegas, NV
Brooklyn, NY
New Hyde Park, NY
New York, NY
Rochester, NY
Valhalla, NY
Cleveland, OH
Cleveland, OH
Dayton, OH
Pittsburgh, PA
Knoxville, TN
Memphis, TN
Dallas, TX
Fort Worth, TX
Houston, TX
Lubbock, TX
San Antonio, TX
Falls Church, VA
Roanoke, VA
Burlington, VT
Milwaukee, WI
Huntington, WV |
|
04/29/2007 |
|
|
|
Details |
|
Combination Therapy With Thalidomide and CPT-11 in Patients With Recurrent Anaplastic Gliomas or Glioblastoma Multiforme |
|
Houston , TX |
|
04/15/2007 |
|
|
|
|
|
Details |
|
RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma |
|
Los Angeles, CA
Dallas, TX |
|
11/21/2006 |
|
|
|
Details |
|
Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
|
|
New York, NY |
|
10/12/2006 |
|
|
|
|
|
Details |
|
TREATMENT OF NEWLY DIAGNOSED, HIGH-GRADE, MALIGNANT GLIOMA WITH POLIFEPROSAN 20 CONTAINING CARMUSTINE IMPLANT (GLIADEL® WAFER) USING MR SPECTROSCOPY DATA AS A PRIMARY INDICATOR OF THERAPEUTIC RESPONSE |
|
New York, NY |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
,
, Canada
, Canada
, Canada
, Canada
, Canada
, Canada
, Switzerland
, Switzerland
Auckland, New Zealand
Perth, Western Australia, 6001, Australia
Randwick, New South Wales, 2031, Australia
Phoenix, AZ
Downey, CA
Loma Linda, CA
Los Angeles, CA
Los Angeles, CA
Los Angeles, CA
Madera, CA
Oakland, CA
Orange, CA
Orange, CA
Sacramento, CA
San Francisco, CA
Santa Barbara , CA
Travis Air Force Base, CA
Denver, CO
Farmington, CT
Washington, DC
Washington, DC
Wilmington, DE
Atlanta, GA
Macon, GA
Savannah, GA
Des Moines, IA
Chicago, IL
Chicago, IL
Park Ridge, IL
Indianapolis, IN
Springfield, MA
Baltimore, MD
Ann Arbor, MI
Detroit, MI
Grand Rapids, MI
Kalamazoo, MI
Royal Oak, MI
Royal Oak, MI
Minneapolis, MN
Rochester, MN
Kansas City, MO
Chapel Hill, NC
Charlotte, NC
Winston-Salem, NC
Fargo, ND
Omaha, NE
Omaha, NE
Brunswick, NJ
Newark, NJ
Paterson, NJ
Summit, NJ
Las Vegas, NV
Albany, NY
Bronx, NY
Brooklyn, NY
Brooklyn, NY
Brooklyn, NY
Brooklyn, NY
New Hyde Park, NY
New York, NY
Stony Brook, NY
Syracuse, NY
Akron, OH
Cincinnati, OH
Cleveland, OH
Columbus, OH
Dayton, OH
Toledo, OH
Portland, OR
Danville, PA
Philadelphia, PA
Pittsburgh, PA
Sioux Falls, SD
Johnson City, TN
Knoxville, TN
Nashville, TN
Amarillo, TX
Austin, TX
Dallas, TX
Houston, TX
Lubbock, TX
San Antonio, TX
San Antonio, TX
Temple, TX
Norfolk, VA
Seattle, WA
Seattle, WA
Spokane, WA
Tacoma, WA
Green Bay, WI
Green Bay, WI
Green Bay, WI
La Crosse, WI
Madison, WI
Marshfield, WI
Marshfield, WI
Huntington, WV |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Birmingham, AL
Scottsdale/Phoenix, AZ
Jacksonville, FL
Cedar Rapids, IA
Des Moines, IA
Missouri Valley, IA
Sioux City, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Rochester, MN
Saint Cloud, MN
Bismarck, ND
Fargo, ND
Lincoln, NE
Allentown, PA |
|
06/26/2006 |
|
|
|
Details |
|
Phase I/II Study of High Dose Irinotecan (Camptosar, CPT-11) in Patients With Recurrent Unresectable Malignant Glioma on Steroids/Anti-Epileptics |
|
Louisville, KY |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors |
|
Los Angeles, CA |
|
05/29/2006 |
|
|
|
Details |
|
A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion |
|
Louisville, KY |
|
05/27/2006 |
|
|
|
|
|
Details |
|
Genetic Epidemiology of Adult-Onset Glioma |
|
Louisville, KY |
|
05/27/2006 |
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Washington, DC
Chicago, IL
Boston, MA
Bethesda, MD
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
05/27/2006 |
|
|
|
|
|
Details |
|
Comparative 2-D Tumor Analysis in Familial Gliomas |
|
Edmonton, Alberta, Canada |
|
05/04/2006 |
|
|
|
Details |
|
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
|
|
Los Angeles, CA
Boston, MA
Ann Arbor, MI
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
05/04/2006 |
|
|
|
|
|
Details |
|
A Phase I Trial Using Combination Irinotecan (CPT-11) and Thalidomide for Recurrent CNS Tumors |
|
Albuquerque, NM |
|
05/02/2006 |
|
|
|
Details |
|
A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas |
|
Durham, NC |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases |
|
Chicago, IL |
|
05/01/2006 |
|
|
|
Details |
|
Pilot Study of the Safety and Accuracy of Fluorothymidine F 18 Positron Emission Tomography in Detecting Recurrent Disease in Patients With Gliomas
|
|
Seattle, WA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
"Head Start" chemotherapy protocol for children less than 10 years old with newly diagnosed high grade primary brain tumors with intent to eliminate irradiation and abbreviate total duration of treatment to 6 months with resultant improved cure rate and quality of survival. |
|
Oakland, CA |
|
05/01/2006 |
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
Oakland, CA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Chicago, IL
Bethesda, MD
Durham, NC
Durham, NC
Lincoln, NE
Philadelphia, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
05/01/2006 |
|
|
|
Details |
|
Phase II trial of Temodar ® plus O6-Benzylguanine in the treatment of patients with Temodar® -resistant malignant glioma.
|
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Pharmacological intervention for learning impaired children surviving treatment for cancer. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Smithtown, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors |
|
La Jolla, CA |
|
12/03/2005 |
|
|
|
Details |
|
Phase I trial of Temodar plus O6-Benzylguanine plus Irinotecan (CPT-11) in the treatment of patients with recurrent/progressive Cerebral anaplastic gliomas. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Phase I trial of Temozolomide (Temodar) and O6-Benzylguanine (o6-bg)in pediatric patients with recurrent brain tumors. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Mobile , AL |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors. |
|
New York, NY |
|
12/03/2005 |
|
|
|
Details |
|
Fractionated Stereotactic Radiosurgery plus Topotecan radiation sensitizer in the treatment of recurrent malignant astrocytoma or as consolidation after external beam radiotherapy. |
|
New York, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Edison, NJ |
|
12/03/2005 |
|
|
|
Details |
|
Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. |
|
Rockville Centre, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gliadel Wafer Implantation For Malignant Gliomas Of The Brain |
|
Smithtown, NY |
|
12/03/2005 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Gliadel in Adults with Recurrent Malignant Gliomas |
|
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Philadelphia, PA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Phase I/II Study of Multiple Light Fiber Interstitial Photodynamic Therapy for Primary and Metastatic Supratentorial Brain Tumors |
|
Hershey, PA |
|
12/03/2005 |
|
|
|
Details |
|
Quality of Life Studies (There are 19 seperate studies listed here) |
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Use of Epilepsy Monitoring And Electrocorticography For Seizure Control In Patients With Brain Tumors |
|
Hackensack, NJ |
|
12/03/2005 |
|
|
|
Details |
|
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
|
|
Bethesda, MD |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
Los Angeles, CA
Boston, MA
Ann Arbor, MI
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
11/27/2005 |
|
|
|
Details |
|
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors |
|
Portland, OR |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas |
|
Lanne, Switzerland |
|
11/27/2005 |
|
|
|
Details |
|
Melphalan and Mannitol in Treating Patients With Central Nervous System Tumors |
|
Portland, OR |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
|
|
San Francisco, CA
Durham, NC
Philadelphia, PA |
|
11/27/2005 |
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Washington, DC
Chicago, IL
Boston, MA
Durham, NC
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Memphis, TN
Houston, TX
Seattle, WA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas (Brainstem glioma, glioblastoma multiforme, gliosarcoma, anaplastic astrocytoma)
|
|
Baltimore, MD |
|
11/27/2005 |
|
|
|
Details |
|
Computer Assisted Stereotactic Navigation For Resection Of Brain Tumors In Children And Adults |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Double sequential high dose Thiotepa with autologous stem cell rescue for patients age <60 years with recurrent malignant brain cancer. |
|
Los Angeles, CA |
|
11/27/2005 |
|
|
|
Details |
|
Endoscopic ventriculostomy for obstructive hydrocephalus in terminal patients with hydrocephalus and brain tumours. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Feasibility of using oral Etoposide combined with escalating doses of Tamoxifen for children with recurrent gliomas |
|
Denver, CO |
|
11/27/2005 |
|
|
|
Details |
|
Frameless Computer Guided Stereotactic Surgery For Brain Tumors |
|
New York, NY |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Functional brain Mapping Of Motor And Speech Areas For Resection Of Tumors Near Functional Areas Of The Brain |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
Details |
|
Genetic Therapy of meningiomas and gliomas in the Malay population in the NorthnEast coast of Malaysia |
|
Kelantan, Malaysia, MALAYSIA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Longitudinal Neuropsychologic Evaluation And Strategic Educational Interventions. |
|
Houston, TX |
|
11/27/2005 |
|
|
|
Details |
|
Multiple Courses of High Dose Chemotherapy With Peripheral Stem Cell Support in Relapsed, Refractory or Progressive Glial Tumors and in Children With Glioblastoma or Incompletely Resected Anaplastic Astrocytoma at the Time of Diagnosis. |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase 2 Trial of Multi-Agent High Dose Chemotherapy Followed By Stem Cell Rescue For High Grade Gliomas in Adults. |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
Details |
|
Phase 2 Trial of Stereotactic Radiosurgery For Recurrent Pediatric Brain Tumors |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
|
Los Angeles, CA
Los Angeles, CA |
|
11/27/2005 |
|
|
|
Details |
|
Pre- and Postoperative Use of ZD1839(Iressa) in Recurrent Glioblastoma, Including Translational Research |
|
Zürich , Switzerland
Los Angeles, CA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Regulus Navigator for use with a three point pinion - frameless stereotactic surgery |
|
New York, NY |
|
11/27/2005 |
|
|
|
Details |
|
Rehabilitation For Brain Tumor Patients. |
|
Houston, TX |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Risk Adapted, Multimodal Therapy In Newly Diagnosed Supratentorial Malignant Glioma, Stratified To KPS. |
|
Kreischa Dresden, GERMANY |
|
11/27/2005 |
|
|
|
Details |
|
Volumetric Stereotactic Procedures |
|
New York, NY |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Adoptive IL-2 activated LAK cell intratumoral immunotherapy implant with adjuvant radiosurgery boost and naturopathic/nutritional immune enhancement. This is for newly diagnosed patients only.
|
|
Newport Beach, CA |
|
11/26/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors and Arteriovenous and Cavernous Malformations |
|
St.Petersburg, Fl |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Intra-arterial carboplatin for supratentorial brain tumors |
|
Fort Worth, TX |
|
11/26/2005 |
|
|
|
Details |
|
Use of interferon for the treatment of gliomas of the brain and spine. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Aggresive emergency tumour debulking and craniectomy for patients with tumours of more than 80ml and glasgow coma scale of less than 8. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/26/2005 |
|
|
|
Details |
|
Chemotherapy,radiotherapy and immunotherapy for brain tumors. |
|
Guangzhou, CHINA (PR) |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Computer assisted minimally invasive image guided surgery for improved resection of malignant brain tumors and frameless stereotactic brain biopsies For Deep Brain Tumors. |
|
Smithtown, NY |
|
11/26/2005 |
|
|
|
Details |
|
Concurrent Temozolomide and Radiotherapy Followed By Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid For Patients With Newly Diagnosed Glioblastoma And Other Malignant Gliomas |
|
New York, NY |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
New York, NY |
|
11/26/2005 |
|
|
|
Details |
|
Intraoperative navigation in neurosurgical patients |
|
Boston, MA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase I study of Photodynamic Therapy with porfimer sodium for refractory brain tumors |
|
Milwaukee, WI |
|
11/26/2005 |
|
|
|
Details |
|
Phase I/II Trial of Temodar and Escalating Doses of Oral VP-16 for Patients with Recurrent Malignant Glioma |
|
Rochester, NY |
|
11/26/2005 |
|
|
|
|
|
Details |
|
PS-341 With Oral Temozolomide in Patients With Advanced Refractory Solid Tumors or Melanoma |
|
Nashville, TN |
|
11/26/2005 |
|
|
|
Details |
|
Reliable Imaging Diagnosis of Recurrent Brain Tumor |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Frameless Computer Assisted Stereotactic Surgery for Resection of Brain Tumors in Adults and Children |
|
Rockford, IL |
|
11/25/2005 |
|
|
|
Details |
|
Frameless Computer Guided Stereotactic Sugery for Resection of Brain Tumors in Adults and Children |
|
Rockford, IL |
|
11/25/2005 |
|
|
|
|
|
Details |
|
Brain tumor surgery using a compact intraoperative MRI
|
|
Manhasset, NY |
|
11/25/2005 |
|
|
|
Details |
|
Long-term survivors of high grade gliomas. |
|
Salt Lake City, UT |
|
11/24/2005 |
|
|
|
|
|
Details |
|
A trial of Dalteparin low molecular weight heparin for primary prophylaxis of venous thromboembolism in brain tumor patients. |
|
Salt Lake City, UT |
|
11/24/2005 |
|
|
|
Details |
|
Use of Hight Dose Tamoxifen For Patients Who Refuse Surgery For meningiomas and Gliomas. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/24/2005 |
|
|
|
|
|
Details |
|
Gene Therapy Of Malignant Gliomas: A Pilot Study of Vaccination With Autologous Glioma-Lysate And Dendritic Cells Admixed With IL-4 Transduced Fibroblasts To Elicit An Immune Response. |
|
Pittsburgh, PA |
|
11/21/2005 |
|
|
|
Details |
|
Oral ST 1481 in adults with Malignant Glioma: a Phase I-II Clinical Trial |
|
Providence, RI |
|
11/21/2005 |
|
|
|
|
|
Details |
|
Fractionated Stretactic Radiotherapy Boost with weekly Paclitaxel in malignant gliomas. |
|
Brooklyn, NY |
|
11/20/2005 |
|
|
|
Details |
|
Phase I Brachytherapy Dose Escalating Study Using the Proxima Therapeutics, Inc. GliaSIte RTS in Patients with Recurrrent Malignant Gliomas |
|
Winston-Salem, NC |
|
11/20/2005 |
|
|
|
|
|
Details |
|
Phase I/II trial of Temodar and escalating doses of Oral VP-16 for patients with recurrent malignant gliomas. |
|
Durham, NC |
|
11/20/2005 |
|
|
|
Details |
|
Phase II treatment with Irinotecan (CPT-11) plus Celebrex® of adults with primary malignant glioma. |
|
Durham, NC |
|
11/20/2005 |
|
|
|
|
|
Details |
|
Streotactic Radiosurgery for brain lesions |
|
Brooklyn, NY |
|
11/20/2005 |
|
|
|
Details |
|
"Head Start" chemotherapy protocol for children less than 10 years old with newly diagnosed high grade primary brain tumors with intent to eliminate irradiation and abbreviate total duration of treatment to 6 months with resultant improved cure rate and quality of survival. |
|
Los Angeles, CA |
|
11/20/2005 |
|
|
|
|
|
Details |
|
Intraoperative MRI for brain tumors |
|
Boston, MA |
|
11/20/2005 |
|
|
|
Details |
|
Stereotactic Radiosurgery for High Grade Gliomas, for Lesions <4cm AND >4cm.
Brachytherapy for Lesions >4cm |
|
Hackensack, NJ |
|
11/20/2005 |
|
|
|
|
|
Details |
|
Activation of A Pilot Comparison Bioavailability Study of Oral and Intravenously Administered Temozolomide (Temodar) in patients with primary CNS malignancies. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
Details |
|
Phase I/II trial of ZD1839 (Iressa) in pediatric patients newly diagnosed with brain stem tumors or incompletely resected supratentorial malignant gliomas. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Phase II study of VNP40101M for the treatment of adults with newly diagnosed or recurrent malignant glioma. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
Details |
|
Phase I treatment with Irinotecan (CPT-11) plus Temozolomide (Temodar) of children with primary recurrent malignant brain tumors. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Phase I trial of Oral Topotecan plus Temodar in the treatment of patients with recurrent/progressive malignant gliomas. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
Details |
|
Phase II trial of Gleevec plus hydroxyurea in the treatment of patients with malignant glioma |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Pilot study of genetic and environmental Risk and outcome for newly diagnosed brain tumor patients and controls. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
Details |
|
Pilot trial of Innohep (Tinzaparin) Low Molecular Weight Heparin for primary prophylaxis of venous thromboembolism in brain tumor patients. |
|
Durham, NC |
|
11/13/2005 |
|
|
|
|
|
Details |
|
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
|
|
, England |
|
11/13/2005 |
|
|
|
Details |
|
Antineoplaston Therapy in Treating Children With Brain Tumors
|
|
Houston, TX |
|
11/11/2005 |
|
|
|
|
|
Details |
|
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
|
|
Washington, DC
Chicago, IL
Baltimore, MD
Memphis, TN
Dallas, TX
Houston, TX |
|
11/11/2005 |
|
|
|
Details |
|
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer |
|
New York, NY |
|
11/11/2005 |
|
|
|
|
|
Details |
|
Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma
|
|
Boston, MA |
|
11/11/2005 |
|
|
|
Details |
|
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma (Glioblastoma multiforme, Gliosarcoma, Anaplastic astrocytoma, PNET, Oligodendroglioma)
|
|
Paterson, NJ
New York, NY |
|
11/11/2005 |
|
|
|
|
|
Details |
|
TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma(or Glioblastoma multiforme) |
|
Washington, DC
Boston, MA
Memphis, TN |
|
11/11/2005 |
|
|
|
Details |
|
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
|
Washington, DC
Chicago, IL
Boston, MA
Durham, NC
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
A Phase I Gliadel and Escalating Doses of Intravenous O6-Benzylguanine Trial in Patients with Recurrent Malignant Glioma |
|
Baltimore, MD |
|
11/09/2005 |
|
|
|
Details |
|
Phase I, Gliadel® & Escalating Doses of Intravenous O6-Benzylguanine in People with Recurrent Malignant Glioma
|
|
Winston-Salem, NC |
|
11/09/2005 |
|
|
|
|
|
Details |
|
Boron Neutron Capture Therapy (BNCT) to Treat Anaplastic Astrocytoma or Glioblastoma That Has Progressed Following Radiotherapy |
|
Helsinki, Finland |
|
11/06/2005 |
|
|
|
Details |
|
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment |
|
, Puerto Rico
Fort Myers, FL
Gainesville, FL
Jacksonville, FL
Pensacola, FL
St. Petersburg, FL
Tampa, FL
West Palm Beach, FL
Augusta, GA
Indianapolis, IN
Grand Rapids, MI
Syracuse, NY
Akron, OH
San Antonio, TX
San Antonio, TX
Temple, TX
Richmond, VA
Green Bay, WI |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Phase I study of Cilengitide in children with refractory brain tumors. |
|
Durham, NC |
|
11/06/2005 |
|
|
|
Details |
|
SWOG (RTOG) 98-13 randomized trial of RT + Temozolomide vs RT + BCNU, versus RT+ Tem + BCNU |
|
Mobile , AL |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma |
|
Memphis, TN |
|
11/06/2005 |
|
|
|
Details |
|
Radiosurgery with the Varian Trilogy system for benign or malignant brain tumors |
|
Mobile , AL |
|
11/06/2005 |
|
|
|
|
|
